Covered recipient · General Payments record
DANIEL R GREEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,399.95
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $857.57 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $671.16 | 8 |
| Abbott Laboratories | $138.96 | 7 |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.95 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $21.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.96 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125049555 | CMS |
| Abbott Laboratories | $16.87 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125049557 | CMS |
| Abbott Laboratories | $20.22 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125049559 | CMS |
| Abbott Laboratories | $19.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125049561 | CMS |
| Abbott Laboratories | $17.10 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125049563 | CMS |
| Abbott Laboratories | $20.49 | 09/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125049565 | CMS |
| Abbott Laboratories | $24.85 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125049567 | CMS |
| Boston Scientific Corporation | $21.50 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092564216 | CMS |
| Medtronic, Inc. | $111.50 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944072 | CMS |
| Medtronic, Inc. | $123.24 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944074 | CMS |
| Medtronic, Inc. | $30.84 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944076 | CMS |
| Medtronic, Inc. | $7.35 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944078 | CMS |
| Medtronic, Inc. | $60.37 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944080 | CMS |
| Medtronic, Inc. | $124.52 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944082 | CMS |
| Medtronic, Inc. | $129.44 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944084 | CMS |
| Medtronic, Inc. | $83.90 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116944086 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.95 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105922773 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.